Hence, considering the plethora of advantages of IL-7, many clinical trials have been registered to uncover the effectiveness of recombinant IL7 in restoring lymphocyte counts in patients with COVID-19 (Table 1) [141]. This evidence concerns the gene IL7 and COVID-19.